A study evaluating the efficacy and safety of vericiguat, a treatment for patients with worsening chronic heart failure, has met the primary efficacy endpoint.
List view / Grid view
Filter the results
Five pharma companies have filed a complaint in Canadian court over new rules intended to lower the price of drugs in the country.
The worldwide trade of the cephalosporin class of antibiotics will increase to $14.1 billion by the end of 2025.
The EMA has announced its approval for marketing authorisation in the EU for Vitrakvi (larotrectinib), used to treat solid tumours with a specific gene mutation.
A new report predicts that the global diabetes drug market will rise to US$58.4 billion by 2025.
NICE has released a Final Appraisal Document recommending Nexavar for the treatment of patients with advanced hepatocellular carcinoma...
Major market players across the US are upping investments in research to innovate on treatment methods and improve ophthalmic drugs action...